Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sha-Bei Xu

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos One|August 24, 2018
Endovascular thrombectomy versus medical treatment for large vessel occlusion stroke with mild symptoms: A meta-analysisYong-Jie Xiong, Jia-Ming Gong, Yi-Chi Zhang, et al.
Chinese Medical Journal|July 26, 2016
Needle Sensation and Personality Factors Influence Therapeutic Effect of Acupuncture for Treating Bell's Palsy: A Secondary Analysis of a Multicenter Randomized Controlled TrialChen-Yan Zhang, Sha-Bei Xu, Bo Huang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 27, 2013
Effectiveness of strengthened stimulation during acupuncture for the treatment of Bell palsy: a randomized controlled trialSha-bei Xu, Bo Huang, Chen-yan Zhang, et al.
Journal of Neuroinflammation|November 7, 2020
Deficiency of microglial Hv1 channel is associated with activation of autophagic pathway and ROS production in LPC-induced demyelination mouse modelMan Chen, Lin-Lin Yang, Zi-Wei Hu, et al.
Stroke and Vascular Neurology|April 16, 2026
Adjunct tirofiban treatment after successful endovascular thrombectomy recanalisation in acute anterior circulation ischaemic stroke (ATTRACTION): protocol of a multicentre, prospective, double-blinded, randomised trialXiang Luo, Hao Huang, Sha-Bei Xu, et al.
Stroke and Vascular Neurology|November 23, 2022
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018Dai-Shi Tian, Chen-Chen Liu, Chao-Long Wang, et al.
Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos One|August 24, 2018
Endovascular thrombectomy versus medical treatment for large vessel occlusion stroke with mild symptoms: A meta-analysisYong-Jie Xiong, Jia-Ming Gong, Yi-Chi Zhang, et al.
Chinese Medical Journal|July 26, 2016
Needle Sensation and Personality Factors Influence Therapeutic Effect of Acupuncture for Treating Bell's Palsy: A Secondary Analysis of a Multicenter Randomized Controlled TrialChen-Yan Zhang, Sha-Bei Xu, Bo Huang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 27, 2013
Effectiveness of strengthened stimulation during acupuncture for the treatment of Bell palsy: a randomized controlled trialSha-bei Xu, Bo Huang, Chen-yan Zhang, et al.
Journal of Neuroinflammation|November 7, 2020
Deficiency of microglial Hv1 channel is associated with activation of autophagic pathway and ROS production in LPC-induced demyelination mouse modelMan Chen, Lin-Lin Yang, Zi-Wei Hu, et al.
Stroke and Vascular Neurology|April 16, 2026
Adjunct tirofiban treatment after successful endovascular thrombectomy recanalisation in acute anterior circulation ischaemic stroke (ATTRACTION): protocol of a multicentre, prospective, double-blinded, randomised trialXiang Luo, Hao Huang, Sha-Bei Xu, et al.
Stroke and Vascular Neurology|November 23, 2022
Prevalence and risk factors of stroke in China: a national serial cross-sectional study from 2003 to 2018Dai-Shi Tian, Chen-Chen Liu, Chao-Long Wang, et al.
Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
Pageof 2